Fox News
US · 58 mins ago
✦ 78◉ Centre
New option available for Alzheimer’s patients as FDA approves expanded drug use
78Accuracy
0Ratings
0Comments
AI Analysis
Accuracy 78/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ✓ Fair headline
The FDA has approved Auvelity as a non-antipsychotic treatment option for agitation in Alzheimer's patients, representing a significant therapeutic advance.
New option available for Alzheimer’s patients as FDA approves expanded drug use
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!